Name
Interprofessional Excellence: Integrating Pharmacists into the MAT Team
Date & Time
Tuesday, April 3, 2018, 12:30 PM - 1:45 PM
Speakers
Bethany DiPaula, PharmD, BCPP, Associate Professor, School of Pharmacy, University of Maryland - Baltimore
Sarah Melton, PharmD, BCPP, BCACP, FASCP, Professor of Pharmacy Practice, Gatton College of Pharmacy, East Tennessee State University
Troy A. Moore, PharmD, MS, BCPP, Clinical Pharmacy Specialist- Psychiatry, South Texas Veterans Health Care System
Sarah Melton, PharmD, BCPP, BCACP, FASCP, Professor of Pharmacy Practice, Gatton College of Pharmacy, East Tennessee State University
Troy A. Moore, PharmD, MS, BCPP, Clinical Pharmacy Specialist- Psychiatry, South Texas Veterans Health Care System
Description
Moderator: Julie Miller, Editor in Chief, Behavioral Healthcare Executive and Addiction Professional
CE Certified By: AMA,AAFP,ACPE,ANCC,APA,NAADAC,NASW,NBCC
Pharmacists are often an underutilized healthcare resource despite their medication expertise and accessibility. Pharmacists are essential healthcare providers who are trained to recognize opioid overdose, opioid use disorder and withdrawal syndromes. Integration of the pharmacist into medication assisted treatment (MAT) teams for opioid use disorders can help improve access and outcomes, while reducing the risk of relapse. When pharmacists partner with prescribers to provide MAT, pharmacists are able to take the lead in developing treatment plans, communicating with patients, improving adherence, monitoring patients, identifying treatment options and performing tasks to alleviate prescriber burden.
This session will demonstrate three different practice settings where psychiatric pharmacists partner with prescribers to provide care collaboratively for patients with substance use disorders. Participants will gain knowledge of innovative ways to include pharmacists on the MAT interprofessional team and how to design and execute effective practice protocols. This presentation is provided in collaboration with the College of Psychiatric and Neurologic Pharmacists.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify the unique training and traits pharmacists bring to the interprofessional treatment team caring for patients with substance use disorders.
- Describe the barriers and benefits encountered in establishing a collaborative practice agreement with prescribers to provide medication assisted treatment.
- Compare outcomes from collaborations integrating pharmacists in the medication assisted treatment care team in different practice settings across the United States.
CE Certified By: AMA,AAFP,ACPE,ANCC,APA,NAADAC,NASW,NBCC
Pharmacists are often an underutilized healthcare resource despite their medication expertise and accessibility. Pharmacists are essential healthcare providers who are trained to recognize opioid overdose, opioid use disorder and withdrawal syndromes. Integration of the pharmacist into medication assisted treatment (MAT) teams for opioid use disorders can help improve access and outcomes, while reducing the risk of relapse. When pharmacists partner with prescribers to provide MAT, pharmacists are able to take the lead in developing treatment plans, communicating with patients, improving adherence, monitoring patients, identifying treatment options and performing tasks to alleviate prescriber burden.
This session will demonstrate three different practice settings where psychiatric pharmacists partner with prescribers to provide care collaboratively for patients with substance use disorders. Participants will gain knowledge of innovative ways to include pharmacists on the MAT interprofessional team and how to design and execute effective practice protocols. This presentation is provided in collaboration with the College of Psychiatric and Neurologic Pharmacists.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify the unique training and traits pharmacists bring to the interprofessional treatment team caring for patients with substance use disorders.
- Describe the barriers and benefits encountered in establishing a collaborative practice agreement with prescribers to provide medication assisted treatment.
- Compare outcomes from collaborations integrating pharmacists in the medication assisted treatment care team in different practice settings across the United States.